RetinalGenix Technologies (RTGN) Enterprise Value (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Enterprise Value of -$180.0 for Q1 2026, up 95.15% on a YoY basis from -$92.24 in Q1 2025, and up 98.78% sequentially from -$14774.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Enterprise Value (2020 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 7 years of Enterprise Value data on file, last reported at -$180.0 in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 95.15% year-over-year to -$180.0; the trailing twelve-month figure through Mar 2026 stood at -$180.0 (up 95.15% YoY), and the FY2025 full-year result was -$14774.0, down 143.8% from the prior year.
- Enterprise Value grew to -$180.0 in Q1 2026, from -$14774.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$27.0 in Q2 2022 to a low of -$86913.0 in Q2 2024.
- A 5-year average of -$16107.7 and a median of -$3093.5 in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 179647.73% in 2024 and jumped 99.88% in 2025, its largest moves.
- Tracing RTGN's Enterprise Value over 5 years: stood at -$38.0 in 2022, then fell by 15.79% to -$44.0 in 2023, then tumbled by 13672.73% to -$6060.0 in 2024, then sank by 143.8% to -$14774.0 in 2025, then jumped by 98.78% to -$180.0 in 2026.
- Business Quant data shows RTGN's Enterprise Value at -$180.0 in Q1 2026, -$14774.0 in Q4 2025, and -$92.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -3.67 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -2.07 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -1.12 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -3.09 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | -180.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -180.00 |
| Dec 31, 2025 | -14,774.00 |
| Sep 30, 2025 | -92.00 |
| Jun 30, 2025 | -839.00 |
| Mar 31, 2025 | -3,711.00 |
| Dec 31, 2024 | -6,060.00 |
| Sep 30, 2024 | -79,089.00 |
| Jun 30, 2024 | -86,913.00 |
| Mar 31, 2024 | -50,386.00 |
| Sep 30, 2023 | -44.00 |
| Jun 30, 2023 | -1,913.00 |
| Mar 31, 2023 | -7,470.00 |
| Dec 31, 2022 | -38.00 |
| Sep 30, 2022 | -3,632.00 |
| Jun 30, 2022 | -27.00 |
| Mar 31, 2022 | -2,555.00 |
| Dec 31, 2021 | -4,947.00 |
| Sep 30, 2021 | -36,578.00 |
| Dec 31, 2020 | -2,219.00 |